Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Leukemia; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Liver Diseases | Phase 4 | ClinicalTrials |
| Esophageal Atresia | Phase 2 | ClinicalTrials |
| Cholestasis | Phase 1/Phase 2 | ClinicalTrials |
| Cholestasis; Liver Diseases | Phase 2 | ClinicalTrials |
| Dyslipidemias; Insulin Resistance; Obesity | Phase 3 | ClinicalTrials |
| Wounds and Injuries | Phase 2 | ClinicalTrials |
| Cholestasis | Phase 2 | ClinicalTrials |
| Cholestasis | Phase 3 | ClinicalTrials |
| Cholestasis | Phase 2 | ClinicalTrials |
| Cholestasis | Phase 1/Phase 2 | ClinicalTrials |
| Cholestasis | Phase 1 | ClinicalTrials |
| Cholestasis | Phase 3 | ClinicalTrials |
| Birth Weight; Premature Birth; Retinal Diseases; Retinopathy of Prematurity | Phase 2 | ClinicalTrials |
| Colonic Neoplasms | Phase 4 | ClinicalTrials |
| Cholestasis; Gastroschisis; Infant, Premature, Diseases; Intestinal Atresia; Short Bowel Syndrome | Phase 2/Phase 3 | ClinicalTrials |
| Death; Death, Sudden, Cardiac; Tachycardia; Tachycardia, Ventricular | Phase 1/Phase 2 | ClinicalTrials |
| Esophageal Neoplasms; Neoplasms; Stomach Neoplasms | Phase 2 | ClinicalTrials |
CONTENTS